Clinical Trial Update: Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates a combination of fludarabine, cyclophosphamide, and thalidomide in treating patients with angioimmunoblastic T-cell lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioimmunoblastic T-cell Lymphoma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Fludarabine (Fludarabine)
• Thalomid (thalidomide)

Snippet

Sponsor: Cancer Research UK | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN